4 medicines held by Alnylam Netherlands B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Amvuttra 25 mg solution for injection in pre-filled syringe EU/1/22/1681/001 |
Vutrisiran Sodium | Alnylam Netherlands B.V. | — |
| Givlaari 189 mg/mL solution for injection EU/1/20/1428/001 |
Givosiran Sodium | Alnylam Netherlands B.V. | — |
| Onpattro 2 mg/mL concentrate for solution for infusion EU/1/18/1320/001 |
PATISIRAN SODIUM | Alnylam Netherlands B.V. | — |
| Oxlumo 94.5 mg/0.5 mL solution for injection EU/1/20/1496/001 |
Lumasiran sodium | Alnylam Netherlands B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.